Web Results
Find Health Information on Healthline
Find Info About:
Healthline is the leading provider of health information.

en.wikipedia.org/wiki/Bruesewitz_v._Wyeth

Bruesewitz v. Wyeth, 562 U.S. 223 (2011), is a United States Supreme Court case that decided whether a section of the National Childhood Vaccine Injury Act of 1986 preempts all vaccine design defect claims against vaccine manufacturers . Contents. [hide]. 1 Background; 2 Decision; 3 See also; 4 References; 5 External ...

www.nejm.org/doi/full/10.1056/NEJMp1102182

Apr 21, 2011 ... On February 22, 2011, the U.S. Supreme Court ruled in Bruesewitz v. Wyeth that vaccine makers are immune from lawsuits charging that the design of a vaccine is defective. Many physicians and public health organizations applauded this outcome, believing that it will help to ensure the availability and ...

supreme.justia.com/cases/federal/us/562/223/opinion.html

RUSSELL BRUESEWITZ, et al., PETITIONERS v. WYETH LLC, fka WYETH, INC., fka WYETH LABORATORIES, et al. on writ of certiorari to the united states court of appeals for the third circuit. [February 22, 2011]. Justice Scalia delivered the opinion of the Court. We consider whether a preemption provision enacted in the  ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2925064

Apr 27, 2010 ... Patients were evaluated over the past decade at McLean Hospital in Boston, Massachusetts, following methods detailed previously (Tohen et al., 2000, 2003; Baldessarini et al., 2010a). Protocols were approved by the McLean Institutional Review Board and subjects provided written, informed consent for ...

caselaw.findlaw.com/us-supreme-court/09-152.html

BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC., ET AL., (2011). No. 09- 152. Argued: October 12, 2010 Decided: February 22, 2011. The National Childhood Vaccine Injury Act of 1986 (NCVIA or Act) created a no-fault compensation program to stabilize a vaccine market adversely affected by an increase in ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2605658

As specific knock-down of cPLA2-α mRNA resulted in significant reductions in cell growth in both cell lines, we aimed to determine if a newly available specific inhibitor of cPLA2-α named Wyeth-1 by Ni et al (15) and also named Gfipladib could also reduce PC cell growth. This compound has been shown not to inhibit ...

www.researchgate.net/publication/263384351_Six_attributes_of_social_resilience

Dec 18, 2017 ... You've got to involve the ground troops, it. involves a bit more efficacy to get them involved in it and ... they drive it from within. 152 K. Maclean et al. Downloaded by [University of Southern Queensland] at 15:08 07 January 2014. 5. Implications for management. The six attributes of social resilience identified ...

www.reedsmith.com/files/uploads/DrugDeviceLawBlog/Guvenoz.pdf

Mar 27, 2015 ... counts VII and VIII, violations of the Illinois Consumer Fraud Act (815 ILCS 505/1 et seq. .... to the labeling in 2005); Wyeth v. ... of America, N.A. v. Adeyiga, 2014 IL App (1st) 131252, ¶ 57 (when reviewing a trial court's decision on a 2-619 motion to dismiss, we accept as true all well-pled facts in the plaintiff's.

journals.sagepub.com/doi/pdf/10.1350/clwr.2009.38.4.390

Belize Alliance for Conservation NGOs v DOE et Al (2004) 64 WIR 68. 95. Bell Houses Ltd v City Wall Properties Ltd .... Harding v Police [1981] 2 NZLR 462. 6. Harrison v Wyeth Laboratories 510 F. Supp 1 (ED Pa, 1980), aff'd 676 F. 2d ..... R v Maclean (1974) 17 CCC (2d) 84, NS Co Ct. 15. R v Martini [1941] NZLR 361. 117.